Experience

Search Experience
SearchClear


Sutherland represents a major pharmaceutical company in California state tax controversy.

ClientLarge pharmaceutical company
Region
California
Description
Sutherland represents one of the largest pharmaceutical companies in a $60 million controversy against the California Franchise Tax Board. This matter involves one of the largest state tax controversies in the company's history as well as one of the largest pending controversy matters at the Franchise Tax Board. The case is international in scope and presents significant and complex combination issues under California law.
Related Practices/Industries

Our Story

Sutherland Asbill & Brennan LLP is an international law firm helping the Fortune 100, industry leaders, sector innovators and business entrepreneurs solve their biggest challenges and reach their business goals. Dedicated to unfaltering excellence in client service, we are known for our business savvy and industry intelligence, providing creative and custom solutions for each of our clients. Industry and business experience makes the difference for our clients.

click to watch Videocast: DOL Fiduciary Rule Litigation Impacts
Videocast: DOL Fiduciary Rule Litigation Impacts
Atlanta, GA
Washington, DC
© 2017 Sutherland Asbill & Brennan LLP / Sutherland (Europe) LLP
MYBRIEFCASE
Add this page to MYBRIEFCASE
Add Page to MYBRIEFCASE
Experience - Sutherland represents a major pharmaceutical company in California state tax controversy.
Current MYBRIEFCASE Pages
Save ChangesDownload MYBRIEFCASEClear All